对慢性淋巴结膜炎的修改后Yiqi Huoxue配方的研究:对临床疗效,功能和炎症的影响
1Department of Traditional Chinese Medicine, Beijing Jingshun Hospital of TCM, Beijing, China.
Medicine
|February 24, 2026
概括
一种经过修改的Yiqi Huoxue配方显著改善了慢性淋巴结膜炎 (CGN) 患者的临床疗效. 这种传统中医方法减少了功能障碍和炎症标志物,支持其作为辅助疗法的使用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性淋巴结膜炎 (CGN) 对健康造成重大负担,需要新的治疗策略.
- 传统的CGN治疗方法往往存在局限性,这突出了需要有效的辅助疗法.
研究的目的:
- 为了评估一个修改的Yiqi Huoxue配方作为CGN患者的辅助治疗的临床疗效.
- 评估配方对CGN患者功能指数,脂质样本和炎症标志物的影响.
主要方法:
- 一项涉及90名CGN患者的回顾性研究,分为观察组 (修改的Yiqi Huoxue配方+常规治疗) 和对照组 (仅常规治疗).
- 干预的持续时间为8周,对临床疗效,功能 (血清肌素,BUN,24hUPQ),脂质样本和炎症标志物 (IL-6,hs-CRP) 的评估.
主要成果:
- 与对照组相比,观察组的临床有效率 (86.67%) 显著高于对照组 (66.67%).
- 在治疗后,观察组的血清肌素,BUN,24hUPQ,甘油三,总胆固醇,LDL-C,IL-6和hs-CRP显著降低.
- 多变量逻辑回归和ROC分析表明,功能和炎症标志物的改善是有利结果的显著预测因素.
结论:
- 经过修改的Yiqi Huoxue配方证明了作为CGN辅助疗法的显著临床疗效.
- 通过改善功能和减少全身炎症,可能减缓疾病进展,很可能实现治疗效益.
- 研究结果支持这种配方在治疗CGN患者的临床应用.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
979
06:46Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
Published on: December 22, 2023
1.2K
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
760
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
760
01:28Chronic Kidney Disease III: Interprofessional Care
503
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
01:17Factors Affecting Renal Clearance: Renal Impairment
524
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
524
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
277
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
277
01:29Acute Kidney Injury III: Clinical Manifestations
1.0K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K
01:11Renal Failure: Dose Adjustments
531
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
531